Société Atossa Genetics Inc Nasdaq
Actions
US04962H2094
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Shu-Chih Chen
FOU | Founder | 62 | 01/12/08 |
Steven Quay
CEO | Chief Executive Officer | 73 | 01/12/08 |
Heather Rees
DFI | Director of Finance/CFO | - | 01/01/17 |
Arezoo Mirad
CTO | Chief Tech/Sci/R&D Officer | - | 04/12 |
Richard Graydon
CTO | Chief Tech/Sci/R&D Officer | - | 25/10/22 |
Delly Behen
ADM | Chief Administrative Officer | - | 01/01/14 |
Eric van Zanten
IRC | Investor Relations Contact | - | 07/12/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Steven Quay
CEO | Chief Executive Officer | 73 | 01/12/08 |
Director/Board Member | 66 | 01/03/14 | |
H. Remmel
BRD | Director/Board Member | 72 | 01/02/12 |
Shu-Chih Chen
FOU | Founder | 62 | 01/12/08 |
Stephen Galli
BRD | Director/Board Member | 77 | 01/07/11 |
Jonathan Finn
BRD | Director/Board Member | 50 | 08/11 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 127 077 462 | 125 230 652 ( 98,55 %) | 0 | 98,55 % |
Action B | 0 | 582 | 0 | 0 |
Coordonnées société
Atossa Therapeutics, Inc.
107 Spring Street
98104, Seattle
+206 588 0256
http://www.atossatherapeutics.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+29,77% | 49,46 Md | |
+1,00% | 42,58 Md | |
+50,47% | 42,49 Md | |
-5,26% | 29,09 Md | |
+13,68% | 26,61 Md | |
-22,99% | 18,64 Md | |
+8,22% | 13,16 Md | |
+32,41% | 12,55 Md | |
-1,62% | 11,98 Md |